Top 5 Breakthrough Pharmaceutical Drugs of the Decade

  1. Camzyos

  2. Peak Sales Estimate at the Time of Approval (USD Billion): 4.1

    Disease: Hypertrophic cardiomyopathy

    Company: Bristol Myers Squibb, MyoKardia

    BMS’s $13.1 billion acquisition of MyoKardia in 2020 was driven by the orphan drug Camzyos, a novel treatment for HOCM. Camzyos’ $75 million in sales in the first half of 2023 suggest it is poised to be a blockbuster drug in the future. BMS’s multi-faceted strategy, balancing innovation with safety, positions Camzyos as a key game-changer.